Amgen (AMGN) Moves 3.5% Higher: Will This Strength Last?

Amgen (AMGN) shares soared 3.5% in the last trading session to close at $285.41. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 6.7% loss over the past four weeks.Amgen’s shares climbed likely after the advisory committee to the European Medicine Agency recommended expanding Uplizna’s use to treat adult patients with active immunoglobulin G4-related disease, a rare autoimmune condition with no approved therapies in the EU. Phase ...